Gennova Biopharmaceuticals, a subsidiary of Emcure Pharmaceuticals, has announced a collaboration with the Coalition for Epidemic Preparedness Innovations (CEPI) to advance the development of a ...

Unite.AI is committed to rigorous editorial standards. We may receive compensation when you click on links to products we review. Please view our affiliate disclosure. Creating a strong brand identity ...

DUBLIN, March 31, 2025 /PRNewswire/ -- Theravance Biopharma, Inc. (NASDAQ: TBPH) will participate in a fireside chat at the Jones Healthcare and Technology Innovation Conference in Las Vegas on ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Max, formerly known as HBO Max, officially has a new logo on Sunday night, March 30. The new logo for Warner Bros. Discovery's steaming platform was unveiled on Sunday evening. The new logo gives ...

MLB Opening Day 2025 is finally upon us and all eyes will be on the Los Angeles Dodgers after their World Series win in 2024. The Dodgers technically already opened their season with a sweep of ...

Novartis is cutting approximately 430 employees from its headquarters in East Hanover, NJ, according to a WARN notice. In December, Novartis announced plans to close the recently acquired MorphoSys ...

BERLIN, Germany and BEIJING, China I March 26, 2025 I Bayer and Suzhou Puhe BioPharma Co.,Ltd., a clinical-stage biotechnology company, today announced that they have entered into a global license ...

INCLINE VILLAGE, Nev., Feb. 28, 2020 /PRNewswire/ -- PDL BioPharma, Inc. ("PDL" or the "Company") (Nasdaq: PDLI) today announced it has entered into a cooperation agreement with Engine Capital ...

Biotech firm Quantum BioPharma said on March 20 that it had now spent $3.5 million in total to buy BTC and other cryptocurrencies after an initial $1 million investment in December. Medical ...

Wedbush initiated coverage of Zenas BioPharma (ZBIO) with an Outperform rating and $35 price target Easily identify stocks' risks and opportunities. Discover stocks' market position with detailed ...

B. Riley initiated coverage of ArriVent Biopharma (AVBP) with a Buy rating and $37 price target The firm sees potential market expansion of the company’s “partially de-risked” treatment for ...